Back
CytoMed Therapeutics Ltd. Stock Predictions
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Sell
29
GDTC
CytoMed Therapeutics Ltd.
Last Price:
$1.88
Seasonality Move:
-6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist NowCytoMed Therapeutics Ltd. Stock Forecast
-
Is CytoMed Therapeutics Ltd. Stock Undervalued?The current CytoMed Therapeutics Ltd. [GDTC] share price is $1.77. The Score for GDTC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
GDTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will CytoMed Therapeutics Ltd. Stock Go Up Next Year?
Data Unavailable
CytoMed Therapeutics Ltd. Stock Rating
Data Unavailable
CytoMed Therapeutics Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Singapore
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomed.sg
52-Week Data
52-Week High:
4.05
52-Week Low:
1.65
Prediction Charts
Market Cap:
20.8M
Price in USD:
1.77
Volume:
11.6K
Beta:
-0.30
Technical Analysis
SMA50:
2.07
SMA100:
1.99
SMA200:
2.18
52-Wk Change:
-39.18%
Stock Predictions
-
Is CytoMed Therapeutics Ltd. stock public?Yes, CytoMed Therapeutics Ltd. is a publicly traded company.
-
What is the CytoMed Therapeutics Ltd. stock quote today?The CytoMed Therapeutics Ltd. stock price is 1.77 USD today.
-
How to buy CytoMed Therapeutics Ltd. stock online?You can buy CytoMed Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 1.98 | 1.98 | 1.99 | 1.93 |
| Nov-18 | 1.99 | 1.97 | 2.29 | 1.88 |
| Nov-19 | 1.80 | 1.81 | 1.99 | 1.78 |
| Nov-20 | 1.85 | 1.80 | 1.98 | 1.78 |
| Nov-21 | 1.84 | 1.88 | 1.88 | 1.80 |
| Nov-24 | 1.86 | 1.91 | 1.91 | 1.86 |
| Nov-25 | 1.87 | 1.90 | 1.91 | 1.86 |
| Nov-26 | 1.86 | 1.90 | 1.94 | 1.86 |
| Nov-28 | 1.85 | 1.84 | 1.87 | 1.84 |
| Dec-1 | 1.83 | 1.81 | 1.98 | 1.81 |
| Dec-2 | 1.82 | 1.74 | 1.82 | 1.74 |
| Dec-3 | 1.73 | 1.75 | 1.75 | 1.72 |
| Dec-4 | 1.75 | 1.85 | 1.88 | 1.75 |
| Dec-5 | 1.71 | 1.77 | 1.80 | 1.71 |
CytoMed Therapeutics Ltd. Earnings
Data Unavailable
CytoMed Therapeutics Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.
* CytoMed Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.